InMed Pharmaceuticals (INM) Competitors $4.40 +0.26 (+6.28%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INM vs. NRXP, CARA, ACXP, AIM, TXMD, HCWB, MRNS, PMCB, AWH, and SLGLShould you be buying InMed Pharmaceuticals stock or one of its competitors? The main competitors of InMed Pharmaceuticals include NRx Pharmaceuticals (NRXP), Cara Therapeutics (CARA), Acurx Pharmaceuticals (ACXP), AIM ImmunoTech (AIM), TherapeuticsMD (TXMD), HCW Biologics (HCWB), Marinus Pharmaceuticals (MRNS), PharmaCyte Biotech (PMCB), Aspira Women's Health (AWH), and Sol-Gel Technologies (SLGL). These companies are all part of the "pharmaceutical products" industry. InMed Pharmaceuticals vs. NRx Pharmaceuticals Cara Therapeutics Acurx Pharmaceuticals AIM ImmunoTech TherapeuticsMD HCW Biologics Marinus Pharmaceuticals PharmaCyte Biotech Aspira Women's Health Sol-Gel Technologies NRx Pharmaceuticals (NASDAQ:NRXP) and InMed Pharmaceuticals (NASDAQ:INM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Is NRXP or INM more profitable? NRx Pharmaceuticals has a net margin of 0.00% compared to InMed Pharmaceuticals' net margin of -137.41%. NRx Pharmaceuticals' return on equity of 0.00% beat InMed Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets NRx PharmaceuticalsN/A N/A -449.16% InMed Pharmaceuticals -137.41%-65.74%-53.57% Which has more volatility and risk, NRXP or INM? NRx Pharmaceuticals has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, InMed Pharmaceuticals has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500. Does the media favor NRXP or INM? In the previous week, NRx Pharmaceuticals had 1 more articles in the media than InMed Pharmaceuticals. MarketBeat recorded 2 mentions for NRx Pharmaceuticals and 1 mentions for InMed Pharmaceuticals. NRx Pharmaceuticals' average media sentiment score of 1.46 beat InMed Pharmaceuticals' score of 0.00 indicating that NRx Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NRx Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMed Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, NRXP or INM? InMed Pharmaceuticals has higher revenue and earnings than NRx Pharmaceuticals. NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than InMed Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNRx PharmaceuticalsN/AN/A-$30.15M-$2.14-0.70InMed Pharmaceuticals$4.96M0.64-$7.68M-$13.91-0.32 Do analysts recommend NRXP or INM? NRx Pharmaceuticals currently has a consensus target price of $32.00, indicating a potential upside of 2,033.33%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe NRx Pharmaceuticals is more favorable than InMed Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NRx Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33InMed Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor NRXP or INM? NRx Pharmaceuticals received 5 more outperform votes than InMed Pharmaceuticals when rated by MarketBeat users. Likewise, 100.00% of users gave NRx Pharmaceuticals an outperform vote while only 47.06% of users gave InMed Pharmaceuticals an outperform vote. CompanyUnderperformOutperformNRx PharmaceuticalsOutperform Votes13100.00% Underperform VotesNo VotesInMed PharmaceuticalsOutperform Votes847.06% Underperform Votes952.94% Do insiders and institutionals believe in NRXP or INM? 4.3% of NRx Pharmaceuticals shares are owned by institutional investors. Comparatively, 20.1% of InMed Pharmaceuticals shares are owned by institutional investors. 19.0% of NRx Pharmaceuticals shares are owned by company insiders. Comparatively, 1.9% of InMed Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryNRx Pharmaceuticals beats InMed Pharmaceuticals on 13 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INM vs. The Competition Export to ExcelMetricInMed PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.16M$6.58B$5.13B$9.07BDividend YieldN/A2.99%5.08%4.23%P/E Ratio-0.3210.4689.5817.17Price / Sales0.64195.791,116.12116.95Price / CashN/A57.1642.8237.86Price / Book0.215.094.774.78Net Income-$7.68M$151.83M$120.15M$225.60M7 Day Performance-16.35%-2.13%-1.92%-1.23%1 Month Performance-5.38%-3.10%11.47%3.36%1 Year Performance-36.49%11.54%30.52%16.60% InMed Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMInMed Pharmaceuticals0.4358 of 5 stars$4.40+6.3%N/A-36.5%$3.16M$4.96M-0.3213News CoverageNRXPNRx Pharmaceuticals3.2971 of 5 stars$1.20-0.1%$32.00+2,568.0%-96.5%$14.51MN/A-0.562News CoveragePositive NewsCARACara Therapeutics4.2221 of 5 stars$0.26-2.6%$2.32+809.4%-29.0%$13.99M$8.69M-0.1555News CoverageGap DownACXPAcurx Pharmaceuticals1.3843 of 5 stars$0.82-4.1%$12.00+1,363.4%-77.0%$13.85MN/A-0.783Gap UpAIMAIM ImmunoTech2.3707 of 5 stars$0.22-0.9%$2.75+1,167.3%-60.4%$13.84M$190,000.00-0.4720TXMDTherapeuticsMD0.4365 of 5 stars$1.17-3.8%N/A-53.8%$13.53M$1.30M0.00420Analyst ForecastGap UpHCWBHCW Biologics0.4069 of 5 stars$0.36-0.5%N/A-60.4%$13.44M$3.50M-0.3640Gap DownMRNSMarinus Pharmaceuticals4.3127 of 5 stars$0.24-9.9%$4.79+1,921.8%-97.6%$13.06M$31.47M-0.10110Analyst ForecastNews CoveragePMCBPharmaCyte Biotech0.4225 of 5 stars$1.70-1.2%N/A-24.8%$13.05MN/A2.612Earnings ReportAWHAspira Women's Health1.3425 of 5 stars$0.76+0.7%$4.40+482.8%-69.7%$12.59M$9.15M-0.62110Analyst ForecastSLGLSol-Gel Technologies2.4264 of 5 stars$0.45-6.0%$5.00+1,008.9%-66.5%$12.56M$1.55M-1.3650 Related Companies and Tools Related Companies NRXP Alternatives CARA Alternatives ACXP Alternatives AIM Alternatives TXMD Alternatives HCWB Alternatives MRNS Alternatives PMCB Alternatives AWH Alternatives SLGL Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INM) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INM Stock Alerts